» Articles » PMID: 17505023

Induction of a Distinct CD8 Tnc17 Subset by Transforming Growth Factor-beta and Interleukin-6

Overview
Journal J Leukoc Biol
Date 2007 May 17
PMID 17505023
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Cross-talk between TGF-beta and IL-6 has been shown to direct the differentiation of CD4(+) cells into special IL-17-secreting cells, which are termed Th17 cells. In this study, we demonstrated that TGF-beta and IL-6 could stimulate CD8(+) cells to differentiate into noncytotoxic, IL-17-producing cells in MLC. These IL-17-producing CD8(+) cells exhibit a unique granzyme B(-)IFN-gamma(-)IL-10(-) phenotype. The mRNA level of Th2/T cytotoxic 2 (Tc2) transcription factors GATA3 and Th1/Tc1 transcription factors T-box expressed in T cell (T-bet) as well as its target H2.O-like homeobox (Hlx) is decreased in CD8(+) cells from TGF-beta- and IL-6-treated MLC. In addition, these CD8(+) cells display a marked up-regulation of retinoic acid-related orphan receptor-gammat, a key IL-17 transcription factor. These results demonstrate that the existence of an IL-17-producing CD8(+) subset belongs to neither the Tc1 nor the Tc2 subset and can be categorized as a T noncytotoxic 17 (Tnc17) subset.

Citing Articles

IL-22, a vital cytokine in autoimmune diseases.

Li J, Wu Z, Wu Y, Hu X, Yang J, Zhu D Clin Exp Immunol. 2024; 218(3):242-263.

PMID: 38651179 PMC: 11557150. DOI: 10.1093/cei/uxae035.


Friend or Foe - Tc17 cell generation and current evidence for their importance in human disease.

Hipp A, Bengsch B, Globig A Discov Immunol. 2024; 2(1):kyad010.

PMID: 38567057 PMC: 10917240. DOI: 10.1093/discim/kyad010.


Levels of Tc17 cells in thymic epithelial cell tumors associated with autoimmune diseases.

Li J, Chen Y, Wang Y, Liu Y, Zhang P Mediastinum. 2022; 3:8.

PMID: 35118237 PMC: 8794461. DOI: 10.21037/med.2019.02.02.


IL-17A/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expression.

Stein S, Henze L, Poch T, Carambia A, Krech T, Preti M J Hepatol. 2020; 74(4):919-930.

PMID: 33197512 PMC: 8778963. DOI: 10.1016/j.jhep.2020.10.035.


Inhibition of the transcription factor ROR-γ reduces pathogenic Th17 cells in acetylcholine receptor antibody positive myasthenia gravis.

Yi J, Russo M, Raja S, Massey J, Juel V, Shin J Exp Neurol. 2019; 325:113146.

PMID: 31838097 PMC: 7357824. DOI: 10.1016/j.expneurol.2019.113146.